Eliezer A. Rachmilewitz

Eliezer A. Rachmilewitz's AcademicInfluence.com Rankings

Philosophy

#6131

World Rank

#9111

Historical Rank

Logic

#3320

World Rank

#4457

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Eliezer A. Rachmilewitz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Eliezer A. Rachmilewitz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A unique natural human IgG antibody with anti-alpha-galactosyl specificity (1984) (653)
MEDICAL PROGRESS : β-thalassemia (2005) (469)
The hypercoagulable state in thalassemia. (2002) (460)
Non‐Specific Serum Iron in Thalassaemia: an Abnormal Serum Iron Fraction of Potential Toxicity (1978) (412)
Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. (2006) (319)
Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran (2006) (294)
Activated oxygen and haemolysis. (1975) (290)
The role of oxidative stress in hemolytic anemia. (2008) (252)
Non-transfusion-dependent thalassemias (2013) (224)
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. (2010) (224)
Studies on the stability of oxyhemoglobin A and its constituent chains and their derivatives. (1971) (215)
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. (1996) (215)
Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants (2006) (211)
Oxidative denaturation of red blood cells in thalassemia. (1990) (202)
The effects of protein conformation on the heme symmetry in high spin ferric heme proteins as studied by electron paramagnetic resonance. (1971) (197)
β‐Thalassaemia and sickle cell anaemia as paradigms of hypercoagulability (2007) (194)
Unstable β-globin mRNA in mRNA-deficient β 0 thalassemia (1981) (185)
Protective effects of tea polyphenols against oxidative damage to red blood cells. (1997) (178)
How I treat thalassemia. (2011) (171)
Phosphatidylserine in the outer leaflet of red blood cells from β‐thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes (1993) (170)
Cardiopulmonary assessment in beta-thalassemia major. (1990) (160)
THE PRESENT STATUS OF THE HETEROGENEITY OF FETAL HEMOGLOBIN IN β‐THALASSEMIA: AN ATTEMPT TO UNIFY SOME OBSERVATIONS IN THALASSEMIA AND RELATED CONDITIONS * (1974) (159)
Lipid membrane peroxidation in beta-thalassemia major. (1976) (158)
Cellular and membrane properties of alpha and beta thalassemic erythrocytes are different: implication for differences in clinical manifestations. (1989) (153)
Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia. (2008) (152)
In‐vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with β‐thalassaemia major (1997) (140)
Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids. (2010) (128)
A chronic hypercoagulable state in patients with β‐thalassaemia major is already present in childhood (1999) (125)
Bone mineral metabolism in adults with β‐thalassaemia major and intermedia (2000) (123)
β-thalassemia intermedia: a clinical perspective. (2012) (119)
Decreased hepcidin mRNA expression in thalassemic mice (2004) (113)
Ovarian tissue banking in patients with Hodgkin's disease: is it safe? (1998) (108)
Evolution of a genetic disease in an ethnic isolate: beta-thalassemia in the Jews of Kurdistan. (1991) (106)
Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome (2007) (105)
Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo. (1995) (102)
ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia. (1999) (101)
Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome. (2014) (99)
Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia. (1989) (98)
mRNA-deficint β°-thaladssemia results from a single nucleotide deletion (1982) (93)
Characterization and comparison of the red blood cell membrane damage in severe human alpha- and beta-thalassemia (1992) (93)
Evidence for tissue iron overload in long‐term hemodialysis patients and the impact of withdrawing parenteral iron (2012) (92)
Iron overload in MDS—pathophysiology, diagnosis, and complications (2010) (91)
Enhanced aggregability of red blood cells of beta-thalassemia major patients. (1996) (90)
Role of Iron in Inducing Oxidative Stress in Thalassemia: Can It Be Prevented by Inhibition of Absorption and by Antioxidants? (2005) (90)
Protective effects of rutin against hemoglobin oxidation. (1994) (90)
In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. (1991) (85)
Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes (2010) (84)
The natural anti‐α‐galactosyl IgG on human normal senescent red blood cells (1986) (84)
Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell‐line HepG2 induced by thalassaemic sera (2006) (82)
The demonstration of ferrihemochrome intermediates in heinz body formation following the reduction of oxyhemoglobin A by acetylphenylhydrazone. (1975) (82)
Thromboembolic complications in beta thalassemia major. (1992) (82)
Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. (1983) (80)
No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2* technique (2007) (80)
Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. (2000) (80)
Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia. (1981) (74)
Cerebral infarction in β-thalassemia intermedia: breaking the silence. (2012) (73)
Genetic analysis of β‐thalassemia intermedia in Israel: Diversity of mechanisms and unpredictability of phenotype (1997) (73)
Mean corpuscular volume of heterozygotes for beta-thalassemia correlates with the severity of mutations. (1992) (72)
Hydroxyl radical generation in β-thalassemic red blood cells (1995) (71)
Isolation, characterization, and immunoprecipitation studies of immune complexes from membranes of beta-thalassemic erythrocytes. (1992) (71)
Severe infections in thalassaemic patients: prevalence and predisposing factors (2006) (70)
The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia (2010) (70)
Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia. (1987) (70)
Superoxide dismutase in red blood cells: method of assay and enzyme content in normal subjects and in patients with beta-thalassemia (major and intermedia). (1976) (69)
Applications and bioefficacy of the functional food supplement fermented papaya preparation. (2010) (65)
Quantitative studies of ferritinlike iron in erythrocytes of thalassemia, sickle-cell anemia, and hemoglobin Hammersmith with Mössbauer spectroscopy. (1979) (65)
Ultrastructural Studies in β‐Thalassaemia Major (1973) (63)
Abnormal low and high density lipoproteins in homozygous beta‐thalassaemia (1991) (62)
Cross‐sectional and longitudinal study of the pituitary‐thyroid axis in patients with thalassaemia major (1993) (60)
mRNA expression of iron regulatory genes in β‐thalassemia intermedia and β‐thalassemia major mouse models (2006) (60)
b -Thalassemia Intermedia: A Clinical Perspective (2012) (58)
Two mutations in the beta-globin polyadenylylation signal reveal extended transcripts and new RNA polyadenylylation sites. (1992) (57)
NOVEL TREATMENT OPTIONS IN THE SEVERE β‐GLOBIN DISORDERS (1995) (55)
Platelet survival in patients with beta‐thalassemia (1989) (53)
mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models. (2006) (53)
Nonspecific serum iron in thalassemia: Quantitation and chemical reactivity (1979) (52)
New trends in the treatment of -thalassemia (2000) (52)
Oxidative damage to human red cells induced by copper and iron complexes in the presence of ascorbate. (1989) (50)
Fermented papaya preparation as redox regulator in blood cells of β‐thalassemic mice and patients (2008) (50)
Vitamin E deficiency in beta-thalassemia major: changes in hematological and biochemical parameters after a therapeutic trial with alpha-tocopherol. (1979) (50)
Left ventricular function in beta-thalassemia and the effect of multiple transfusions. (1978) (49)
Self‐renewal and commitment to differentiation of human leukemic promyelocytic cells (HL‐60) (1982) (49)
Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with β-thalassaemia intermedia (2010) (48)
Erythrocyte membrane alterations in beta-thalassaemia. (1985) (48)
Impaired erythrocyte calcium homeostasis in beta-thalassemia. (1984) (48)
Nonrandom association of free iron with membranes of sickle and beta-thalassemic erythrocytes. (1993) (48)
Iron overload in hematological disorders. (2017) (47)
Pulmonary thromboembolism in thalassemia intermedia patients. (1999) (44)
Cerebrovascular accident in β‐thalassemia major (β‐TM) and β‐thalassemia intermedia (β‐TI) (2008) (44)
Addition of fresh frozen plasma as a source of complement to rituximab in advanced chronic lymphocytic leukaemia. (2007) (44)
Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow. (1972) (44)
FORMATION OF HEMICHROMES FROM OXIDIZED HEMOGLOBIN SUBUNITS * (1969) (43)
Juvenile leg ulceration in beta-thalassemia major and intermedia. (1982) (41)
Administration of erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial. (1991) (41)
The role of endocytic pathways in cellular uptake of plasma non-transferrin iron (2012) (40)
Administration of erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial [letter] (1991) (39)
Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL. (2008) (39)
Increased platelet adhesion under flow conditions is induced by both thalassemic platelets and red blood cells (2008) (37)
Non‐transferrin bound iron in Thalassemia: Differential detection of redox active forms in children and older patients (2012) (37)
Splenectomy in Homozygous Beta Thalassaemia: A Retrospective Study of 30 Patients (1975) (37)
Amelioration of oxidative stress in red blood cells from patients with β‐thalassemia major and intermedia and E‐β‐thalassemia following administration of a fermented papaya preparation (2010) (37)
The erythrocyte membranes in beta-thalassemia. Lower sialic acid levels in glycophorin. (1980) (36)
Genetic and molecular diversity in nondeletion Hb H disease. (1981) (36)
Alterations in the red blood cell membrane and the effect of vitamin E on osmotic fragility in beta-thalassemia major. (1976) (35)
Stimulation of proliferation of human myeloid leukemia cells in culture: applications for cytogenetic analysis. (1986) (35)
Generation of procoagulant activity (PCA) by phorbol-esters-induced macrophages derived from a leukemic promyelocytic cell line (HL-60) (1982) (35)
Bone density, mineral content, and cortical index in patients with thalassemia major and the correlation to their bone fractures, blood transfusions, and treatment with desferrioxamine (1992) (35)
Pathophysiology of a- and -thalassemia: Therapeutic implications (2001) (35)
Pathophysiology and treatment of patients with beta-thalassemia – an update (2017) (35)
SUCCESSFUL FULL-TERM PREGNANCY IN HOMOZYGOUS β-THALASSEMIA MAJOR: CASE REPORT AND REVIEW OF THE LITERATURE (1989) (34)
Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies. (2017) (34)
Urinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis (2008) (33)
Erythropoietin activity in the serum of beta thalassemic patients. (2009) (33)
PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA BY T-CELL DEPLETION INVITRO PRIOR TO TRANSPLANTATION (1985) (32)
A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major. (1993) (32)
Iron chelation therapy in patients with myelodysplastic syndromes: consensus conference guidelines. (2008) (31)
The effect of central nervous system stimulation on erythropoiesis in rats with chronically implanted electrodes. (1966) (31)
Denaturation of the normal and abnormal hemoglobin molecule. (1974) (30)
Essential cryofibrinogenemia. Clinical, pathological and immunological studies. (1970) (30)
Noninvasive analysis of skin iron and zinc levels in beta-thalassemia major and intermedia. (1985) (30)
Thalassemia major 1995: older patients, new therapies. (1995) (30)
Tumor Lysis Syndrome Following Treatment with 2-Chlorodeoxyadenosine for Refractory Chronic Lymphocytic Leukemia (1993) (30)
Iron dosing in kidney disease: inconsistency of evidence and clinical practice. (2015) (30)
Prevalence of iron deficiency and anemia among strenuously trained adolescents. (2005) (29)
Molecular follow-up of disease progression and interferon therapy in chronic myelocytic leukemia. (1997) (29)
Enhanced generation of monocyte tissue factor and increased plasma prothrombin fragment1+2 levels in patients with polycythemia vera: Mechanism of activation of blood coagulation (1997) (29)
Phagocytosis of Nucleated and Mature β Thalassaemic Red Blood Cells by Mouse Macro‐phages in Vitro (1979) (28)
High incidence of cholelithiasis in older patients with homozygous beta-thalassemia. (1990) (28)
Studies on curcumin and curcuminoids: XXVI. Antioxidant effects of curcumin on the red blood cell membrane (1996) (27)
In vitro generation of procoagulant activity by leukemic promyelocytes in reponse to cytotoxic drugs (1985) (26)
A noninvasive method for the evaluation of tissue iron deposition in beta-thalassemia major. (1978) (26)
Calcium transport and ultrastructure of red cells in beta-thalassemia intermedia. (1988) (26)
THE RED BLOOD CELL MEMBRANE IN THALASSAEMIA (1980) (26)
Iron incorporation into ferritin and hemoglobin during differentiation of murine erythroleukemia cells. (1981) (26)
Prevalence of beta-thalassemia trait and glucose-6-phosphate dehydrogenase deficiency in Iranian Jews. (2008) (25)
2 Haemoglobinopathies and red cell membrane function (1993) (24)
Exploring the Role of Hepcidin, an Antimicrobial and Iron Regulatory Peptide, in Increased Iron Absorption in β‐Thalassemia (2005) (24)
Future alternative therapies for β-thalassemia (2009) (24)
Nonrandom Association of Free Iron With Membranes of Sickle and β-Thalassemic Erythrocytes (1993) (24)
Hemichromes in single inclusion bodies in red cells of beta thalassemia. (1972) (24)
New trends in the treatment of beta-thalassemia. (2000) (23)
A new polymorphism in the human beta-globin gene useful in antenatal diagnosis. (1981) (23)
Studies in cryofibrinogenemia. (1969) (23)
Oxidative stress contributes to hemolysis in patients with hereditary spherocytosis and can be ameliorated by fermented papaya preparation (2011) (22)
Acute Promyelocytic Leukaemia: A Report of Five Cases with a Comment on the Diagnostic Significance of Serum Vitamin B12 Determination (1972) (22)
mRNA-deficient beta o-thalassemia results from a single nucleotide deletion. (1982) (21)
The role of splenectomy in Gaucher's disease. (1983) (20)
Paravertebral extramedullary hematopoiesis associated with improvement of anemia in congenital dyserythropoietic anemia type II (1986) (20)
Homozygous beta0- and beta+ - thalassemia in Kurdish Jews and Arabs. (1977) (20)
Pathophysiology of alpha- and beta-thalassemia: therapeutic implications. (2001) (20)
Frequency and distribution of asymptomatic brain lesions in patients with β-thalassemia intermedia (2012) (20)
Deferoxamine improves left ventricular function in beta-thalassemia. (1986) (19)
Inadequate utilization of routine electronic RBC counts to identify beta thalassemia carriers. (1988) (19)
Sickle cell trait in a white Jewish family presenting as splenic infarction at high altitude (1988) (19)
Advances in the pathophysiology and treatment of thalassemia. (1995) (19)
Characterization and comparison of the red blood cell membrane damage in severe human alpha- and beta-thalassemia. (1992) (19)
Blood group phenotypes and the origin of sickle cell hemoglobin in Sicilians. (1978) (19)
[The preleukemic syndrome]. (1979) (19)
Haemoglobinopathies and red cell membrane function. (1993) (18)
Decreased hemolysis following administration of antioxidant—fermented papaya preparation (FPP) to a patient with PNH (2010) (18)
The frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia major (2015) (18)
The interaction of hemoglobin O Arab with Hb S and β+ thalassemia among Israeli Arabs (1985) (18)
Aseptic cavernous sinus thrombosis after internal carotid arterial occlusion in polycythaemia vera. (1976) (17)
Juvenile myeloid leukemia with fetal erythropoiesis (1972) (17)
No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/β0‐thalassaemia (2010) (17)
Haemichrome formation during the in vitro oxidation of Hb Köln. (1973) (17)
Cerebrovascular accident in beta-thalassemia major (beta-TM) and beta-thalassemia intermedia (beta-TI). (2008) (17)
VITAMIN E DEFICIENCY DUE TO INCREASED CONSUMPTION IN β‐THALASSEMIA AND IN GAUCHER'S DISEASE * (1982) (17)
Molecular Follow-Up of Disease Progression and Interferon Therapy in Chronic Myelocytic Leukemia (1997) (17)
Darbepoetin alfa for the treatment of anaemia in alpha‐ or beta‐ thalassaemia intermedia syndromes (2011) (16)
Serum antibodies against desipramine as a possible cause for thrombocytopenia. (1968) (16)
Spectrum of β‐thalassemia mutations in the Gaza area (1995) (16)
Relief of pruritus by cholestyramine in chronic liver disease. (1965) (15)
Bone marrow transplantation in thalassaemia. (1986) (15)
ULTRASTRUCTURE OF THE INCLUSION BODIES AND NUCLEAR ABNORMALITIES IN β‐THALASSEMIC ERYTHROBLASTS * (1974) (15)
Hemoglobin Switching in Humans Is Accompanied by Changes in the Ratio of the Transcription Factors, GATA-1 and SP1 (1995) (15)
Incidence of anemia and iron deficiency in strenuously trained adolescents: results of a longitudinal follow-up study. (2009) (15)
Differences in the Pathophysiology of Hemolysis of α‐ and β‐Thalassemic Red Blood Cells (1990) (15)
GLOBIN SYNTHESIS IN SEVERE AND INTERMEDIATE HOMOZYGOUS β THALASSEMIA IN ISRAEL * (1980) (15)
Evolution of a genetic disease in an ethnic isolate : ,-Thalassemia in the Jews of Kurdistan ( mutations / human I-globin gene / polymerase chain reaction / malarial selection ) (14)
Hydroxyl radical generation in beta-thalassemic red blood cells. (1995) (14)
Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases. (1995) (14)
Dapsone-induced methemoglobinemia and hemolysis in the presence of familial hemoglobinopathy Hasharon and familial methemoglobin reductase deficiency. (1981) (14)
The role of intracellular hemoglobin precipitation, low MCHC, and iron overload on red blood cell membrane peroxidation in thalassemia. (1976) (14)
Myelofibrosis, osteolytic bone lesions and hypercalcemia in chronic myeloid leukemia. (1973) (14)
Primaquine-induced superoxde production by β-thalassemic red blood cells (1992) (14)
[The prevention programs for beta thalassemia in the Jezreel and Eiron valleys: results of fifteen years experience]. (2002) (14)
ELLIS-VAN CREVELD SYNDROME. REPORT OF ONE CASE ASSOCIATED WITH ABIOTROPHY OF ELASTIC TISSUE IN THE CARDIOVASCULAR SYSTEM. (1964) (14)
Iron storage in ferritin following intracellular hemoglobin denaturation in erythroleukemic cells. (1983) (14)
Beta O-thalassemia intermedia (1978) (13)
Phagocytosis of nucleated and mature beta thalassaemic red blood cells by mouse macrophages in vitro. (1979) (13)
Hemoglobinopathies in Israel. (1983) (13)
Thrombotic thrombocytopenic purpura: The israeli experience (1992) (13)
Growth and sexual development before and after sex steroid therapy in patients with thalassemia major. (1984) (13)
Increased Hepcidin Expression in Mice Affected by β-Thalassemia Reduces Iron Overload with No Effect on Anemia (2008) (12)
Improvement of Oxidative Stress Parameters in MDS Patients with Iron Overload Treated with Deferasirox (2008) (12)
A naturally occurring anti-alpha-galactosyl IgG recognizing senescent human red cells. (1985) (12)
Molecular Analysis of β-Thalassemia in Vietnam (2000) (12)
Blood Group Phenotypes and Hemoglobin S (1976) (12)
Changes in cellular ferritin content during myeloid differentiation of human leukemic cell lines (1985) (12)
"Lysosomal" enzyme activities in red blood cells of normal individuals and patients with homozygous beta-thalassaemia. (1979) (12)
ABL 1 Methylation Is a Distinct Molecular Event Associated With Clonal Evolution of Chronic Myeloid Leukemia (1999) (12)
Sporadic alleles, including a novel mutation, characterize β‐thalassemia in ashkenazi jews (1993) (12)
The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. (1986) (11)
SUSCEPTIBILITY OF THALASSEMIC RED BLOOD CELLS TO PHAGOCYTOSIS BY HUMAN MACROPHAGES IN VITRO (1980) (11)
Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma. (2002) (10)
Bone marrow transplantation in beta-thalassemia major. The Israeli experience. (1988) (10)
Erratum: “Cerebrovascular accident in β‐thalassemia major (β‐TM) and β‐thalassemia intermedia (β‐TI)” by Karimi et al. Am J Hematol 83:77–79, 2008, DOI number 20938 (2010) (10)
Endometrial glandular haemosiderosis in homozygous beta-thalassaemia. (1989) (10)
Improved method for diagnosis of polycythemia vera based on flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture (1997) (10)
GLYCOGEN STORAGE DISEASE: REPORT OF A CASE WITH GENERALIZED GLYCOGENOSIS WITHOUT DEMONSTRABLE ENZYME DEFECT. (1965) (10)
EXPERIMENTAL NITROFURANTOIN POLYNEUROPATHY IN RATS; EARLY HISTOLOGICAL AND ELECTROPHYSIOLOGICAL ALTERATIONS IN PERIPHERAL NERVES. (1965) (9)
Sickle cell disease in Sicily. (1980) (9)
Distribution of sialic acids on the red blood cell membrane in beta thalassaemia. (1978) (9)
Oxidative Stress in Red Blood Cells, Platelets and Polymorphonuclear Leukocytes from Patients with Myelodysplastic Syndrome. (2006) (9)
A mouse model to study thrombotic complications of thalassemia. (2015) (9)
Splenectomy, Iron Overload and Liver Cirrhosis in β-Thalassemia Major (1976) (9)
Reduced frequency of iron deficiency anaemia in sickle cell trait. (2009) (9)
Does erythropoietin have a role in the treatment of β-hemoglobinopathies? (2014) (9)
Hepcidin Expression in Cultured Liver Cells Responds Differently to Iron Overloaded Sera Derived from Patients with Thalassemia and Hemochromatosis. (2004) (8)
Left ventricular filling and emptying patterns in anemia due to beta thalassemia. A computer-assisted echocardiographic study. (1982) (8)
Molecular studies of beta-thalassemia in Israel. Mutational analysis and expression studies. (1990) (8)
Differentiation of human myeloid leukemic cells by phorbol esters: Correlation with tumor promotion (1984) (8)
How I treat How I treat thalassemia (2011) (8)
Aplastic anemia after prolonged ingestion of indomethacin. (1982) (7)
Prenatal diagnosis of heterozygous beta-thalassemia. (1976) (7)
Differences in the pathophysiology of hemolysis of alpha- and beta-thalassemic red blood cells. (1990) (7)
Induction of differentiation of myeloid leukemic cells by busulphan: in vivo and in vitro observations. (1993) (7)
PROLACTIN RESPONSIVENESS TO TRH AND METOCLOPRAMIDE IN THALASSAEMIA (1982) (7)
Recurrent transient bone marrow hypoplasia associated with pregnancy. (1993) (7)
Heterogeneity of fetal hemoglobin among Israel families with beta-thalassemia. (1973) (7)
Vitamin E deficiency due to increased consumption in beta-thalassemia and in Gaucher's disease. (1982) (7)
P-261 Ovarian failure post-chemotherapy in young cancer patients-risk assessment indicate the need for intervention (1997) (7)
Efficient Introduction and Transient Expression of Exogenous Genes in Human Hemopoietic Cells a (1987) (7)
Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia. (1993) (6)
Intrinsic potential for high fetal hemoglobin production in a Druze family with β-thalassemia is due to an unlinked genetic determinant (1990) (6)
The effect of an antiserotonin agent pizotifen on platelet aggregability in migraine patients. (1980) (6)
Use of Jak2 Inhibitors to Limit Ineffective Erythropoiesis and Iron Absorption in Mice Affected by β-Thalassemia and Other Disorders of Red Cell Production. (2009) (6)
The role of methylation in CML. (2000) (6)
Studies of left-ventricular function in anemia due to beta-thalassemia. (1982) (6)
Deferiprone ( L l ) Chelates Pathologic Iron Deposits From Membranes of Intact Thalassemic and Sickle Red Blood Cells Both In Vitro and In Vivo (2002) (6)
New trends in the treatment of b-thalassemia (2000) (6)
P105 Decrease in intra- and extra-cellular free iron species and oxidative stress parameters and increase in serum and urinary hepcidin during treatment with deferasirox in iron-loaded patients with MDS (2009) (6)
Heme Arginate Therapy forBeta Thalassemia:In vitro versus in vivo Effects (1998) (6)
Iron chelation in thalassemia: mechanism of desferrioxamine action. (1978) (6)
Beta-thalassemia: analysis of mRNA precursors of a mutant human globin gene with defective splicing using peripheral blood nucleated red blood cells. (1986) (6)
Hypercalcemia complicating a megakaryoblastic crisis of chronic myelocytic leukemia. (1988) (6)
HYPERGAMMAGLOBULINEMIC PURPURA AND CRYOGLOBULINEMIA (1978) (6)
Down Regulation of Hepcidin and Haemojuvelin Expression in the Hepatocyte Cell-Line HepG2 Induced by Thalassaemic Sera. (2006) (6)
THE PRICE OF MERCY: COMMENT TO THE PAPER "PREVENTION OF BETA-THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS” BY KOREN ET AL (2014) (5)
The Effect of Fermented Papaya Preparation on Radioactive Exposure (2015) (5)
TSH secretion in thalassemia (1984) (5)
Intermediate hemichrome formation after oxidation of three unstable hemoglobins (Freiburg, Riverdale-Bronx and Köln). (1972) (5)
Flow cytometric analysis of the ploidy of normoblasts in the peripheral blood of patients with beta‐thalassemia (1993) (5)
Stimulation of proliferation of human myeloid leukemia cells by a specific growth factor: Applications for cytogenetic analysis (1986) (5)
Separation of α- and β-chains of hemoglobin A by acetyl-phenylhydrazine (1974) (5)
C0431: High Incidence of Thrombotic Cerebral Lesions in Adult Patients with Beta-Thalassemia Major (2014) (5)
Globin Synthesis in Bone Marrow Cells of Patients with Sickle Cell Anemia and βO-Thalassemia: Contamination of the β-Chain with Non-Globin Proteins (1979) (5)
STUDIES ON HEMOGLOBIN. I. ANTIGENIC PROPERTIES OF HUMAN, CANINE AND RABBIT HEMOGLOBIN SOLUTIONS. (1963) (5)
Expression of Genes Regulating Iron Metabolism in Hepatocyte Cell-Line HepG2 Induced by Sera from MDS Patients. (2007) (5)
Evaluating the impact of age and disease on survival of chronic lymphocytic leukaemia patients by a new method (2009) (4)
New Insights on β-Thalassemia in the Palestinian Population of Gaza: High Frequency and Milder Phenotype Among Homozygous IVS-I-1 (HBB: c.92+1G>A) Patients with High Levels of Hb F (2017) (4)
Frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia major compared to healthy individuals (2016) (4)
Gonadotrophin, thyrotrophin and prolactin reserve in beta thalassaemia. (1978) (4)
Absence of beta mRNA in beta0-thalassemia in Kurdish Jews. (1978) (4)
Beta O-thalassemia intermedia. (1978) (4)
Lactose intolerance is not the cause of gastrointestinal adverse effects in beta thalassemia patients treated with deferasirox (2014) (4)
Establishment of a fetoscopy and fetal blood sampling program in Israel. (1981) (4)
Elevated systemic heme and iron levels as risk factor for vascular dysfunction and atherosclerosis: Evidence from a beta-thalassemia cohort study. (2017) (4)
Urinary Hepcidin Excretion in Patients with Myelodysplastic Syndrome (MDS) and Myelofibrosis (MF). (2006) (4)
β°-Thalassemia Complicated by Autoimmune Hemolytic Anemia (1980) (4)
MULTIPLE PULMONARY INFARCTIONS CAUSED BY BONE-MARROW EMBOLI. (1965) (4)
Hairy cell leukemia: results of 2-chlorodeoxyadenosine therapy in Jerusalem. (1994) (4)
A therapeutic trial in anemia of pregnancy. (1968) (4)
Characterization of the normoblast population in beta-thalassaemic blood by rapid-flow cytofluorometry. (2009) (4)
Disseminated intravascular coagulation in two patients with histiocytic medullary reticulosis. (1984) (4)
The Inhibitory Effect of Vitamin E on Desferrioxamine-Induced Iron Excretion in Rats 1 (1976) (3)
Pancytopenia with hypercellular hemopoietic tissue. (1969) (3)
Splenectomy, iron overload and liver cirrhosis in beta-thalassemia major. (1976) (3)
Spectrum of beta-thalassemia mutations in the Gaza area. (1995) (3)
Blood group phenotypes and hemoglobin S. An anthropologic study in two Israeli Arab communities. (1976) (3)
Alterations in structure, function, and Ca++ content of thalassemic red blood cells. (1983) (3)
[Thalassemia minor and iron deficiency anemia among Israeli soldiers]. (1986) (3)
S17.1. Enhanced aggregability of red blood cells of β-thalassemia major patients; Monitoring by computerized image analysis (1995) (3)
Bone marrow transplantation with T-cell depleted allografts for the treatment of severe beta thalassemia major. (1989) (3)
Globin synthesis in severe and intermediate homozygous beta thalassemia in Israel. (1980) (3)
MÖSSBAUER STUDIES OF FERRITIN-LIKE IRON IN RED BLOOD CELLS OF THALASSEMIA SICKLE-CELL ANEMIA AND HEMOGLOBIN HAMMERSMITH (1979) (3)
Potential Therapeutic Applications of Jak2 Inhibitors in Beta-Thalassemia and Sickle Cell Disease, (2011) (3)
Therapy of acute promyelocytic leukemia with all-trans retinoic acid (1993) (3)
Oxidative Stress of RBC in a Murine Model of Beta-Thalassemia Can Be Reversed by Treatment with Antioxidants. (2005) (2)
Results of therapy in adult acute nonlymphoblastic leukemia: experience in Jerusalem, Israel, during 1975-1982. (1985) (2)
Cell-mediated immunity in idiopathic autoimmune haemolytic disease. (1975) (2)
Procainamide-induced hemolytic anemia in a patient with traumatic cardiac hemolytic anemia. (1981) (2)
Labile Iron: Potential Toxicity in Iron Overload Disorders (2015) (2)
Acute Promyelocytic Leukemia in Childhood (1979) (2)
Hepcidin as a Therapeutic Tool to Limit Iron Overload and Improve Anemia In β-Thalassemia (2010) (2)
P032 Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome (2007) (2)
beta 0-Thalassemia complicated by autoimmune hemolytic anemia. Globin synthesis during immunosuppressive therapy. (1980) (2)
Detection of Specific Bglobin Mutations in Kurdish Jews with β-Thalassmia (1988) (2)
Bone marrow transplantation in beta-thalassemia major with prevention of graft-vs-host disease. (1988) (2)
The Price of Mercy: Comment to the Paper Entitled “Prevention of Beta Thalassemia In Northern Israel - A Cost-Benefit Analysis” by Koren et Al. recently published in Mediterranean Journal of Hematology and Infectious Diseases (2014) (2)
Repeated resuscitation in a patient with myocardial infarction (1963) (2)
Defibrination Syndrome Followed by Hypercoagulable State (1967) (2)
RECOIL-FREE ABSORPTION IN THALASSEMIC RED BLOOD CELLS (1976) (2)
Vitamin E deficiency in fl-thalassemia major: changes in hematological and biochemical parameters after a therapeutic trial with (1979) (2)
Age-adjusted survival gained by treatment: an alternative way of presenting survival. (2005) (1)
[Central nervous system involvement in acute myelogenous leukemia]. (1979) (1)
Detection of specific beta-globin mutations in Kurdish Jews with beta-thalassemia. (1988) (1)
[Active vaccination against hepatitis-B virus infection in thalassemia]. (1986) (1)
Pathologic changes of red blood cell membranes in thalassemia. Morphologic, metabolic, and biochemical changes in thalassemic RBC membranes. (1982) (1)
Identification of Iron Agglomerates by T2* MRI In Major Organs of Patients with End-Stage Renal Disease Who Receive Regularly Erythropoietin with Intravenous Iron (2010) (1)
A critical appraisal of intravenous ﬂ uids: from the physiological basis to clinical evidence (2015) (1)
[Prenatal diagnosis of beta-thalassemia using genetic engineering techniques]. (1982) (1)
Gaucher Disease and Multiple Myeloma: A Diagnostic and Treatment Challenge (2011) (1)
The Oral Iron Chelator Deferiprone Decreases Iron Overload and Oxidative Stress in Transfusion Dependent Patients with Myelodysplastic Syndromes (MDS) (2017) (1)
Splicing Factor 3b Subunit 1 (SF3B1) mediates Mitochondrial Iron Overload In Myelodysplastic Syndromes With Ring Sideroblasts By Alternative Splicing Of Mitoferrin-1 (SLC25A37) (2013) (1)
Separation of alpha- and beta-chains of hemoglobin A by acetylphenylhydrazine. (1974) (1)
Absence of Functional β - Globin Messenger Rna in Kurdish Jews With β0-Thalassemia (1979) (1)
T2* MRI Provides No Evidence for Myocardial and Pancreatic Iron Overload in Multitransfused Patients with Sickle/β-Thalassemia. (2008) (1)
Oxidative Stress Contributes to Hemolysis in Hereditary Spherocytosis. (2007) (1)
Myelofibrosis in young adults. (1983) (1)
Oxidative Imbalance in Hereditary Hemoglobinopathies: The Role of Reactive Oxygen Species in the Pathophysiology of Sickle Cell Anemia and Thalassemia (2003) (1)
[The clinical significance of abnormal hemoglobins]. (1970) (1)
Effect of central nervous system stimulation on erythropoiesis in the rat. (1965) (1)
Systemic Heme and Iron Overload Results in Depletion of Serum Hemopexin, Haptoglobin and Transferrin and Correlates with Markers of Endothelial Activation and Lipid Oxidation in Beta Thalassemia Major and Intermedia (2016) (1)
Primaquine-induced superoxide production by beta-thalassemic red blood cells. (1992) (1)
Platelets and PMN as Well as RBC of Patients with Sickle Cell Anemia Exhibit Oxidative Stress Which Can Be Corrected by Antioxidants. (2004) (0)
[ENDOCARDIAL FIBROELASTOSIS]. (1964) (0)
of ferroportin up-regulation iron absorption mediated by down-regulation of hepcidin and -thalassemia is characterized by increased β Ineffective erythropoiesis in (2013) (0)
Toxicity of Iron Overload (IOL) and IOL Reduction in Hematopoietic Stem Cell Transplantation (SCT) for Hematologic Malignancies (HM) Including MDS (2017) (0)
murine erythroleukemia cells Iron incorporation into ferritin and hemoglobin during differentiation of (2011) (0)
Hydrolase activities in normoblasts of beta-thalassemic patients. (1978) (0)
Priapism in a non-black with sickle cell anemia associated with alpha-thalassemia. (1981) (0)
Successful therapy in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine (2CdA) - single institute experience (1993) (0)
No Evidence for Iron Overload in the Heart of Multitransfused Elderly Patients with Sideroblastic Anemia (RARS) Measured by T2* MRI. (2005) (0)
Contents, Vol. 70, 1983 (1983) (0)
THE EFFECT OF FERMENTED PAPAYA PREPARATION (FPP) UPON RADIOACTIVE EXPOSURE (2016) (0)
P034 Urinary hepcidin excretion in patients with myelodysplastic syndrome (MDS) and myelofibrosis (MF) (2007) (0)
Anemia and Iron Deficiency in Strenuously Trained Adolescents. (2007) (0)
[The mechanism of response of the activated macrophage]. (1981) (0)
Contents, Vol. 62, 1979 (1979) (0)
Thrombotic Thrombocytopenic Purpura: The Israeli Experience Amiram Eldor (1992) (0)
Two mutations in the fi-globin polyadenylylation signal reveal extended transcripts and new RNA polyadenylylation sites ( Jthalassemla / RNA processilg / polymerase chain reaction ) (0)
O-148 Prevention of vaginal hemorrhage in thrombocytopenic cancer patients during chemotherapy treatments (1997) (0)
RED BLOOD CELL MEMBRANE DEFECTS IN β THALASSEMIA AND THE THERAPEUTIC ROLE OF α-TOCOPHEROL (VITAMIN E) (1979) (0)
Faculty Opinions recommendation of HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia. (2017) (0)
Editorial [Hot Topic:Genetic Disorders of Hemoglobin: Sickle Cell Anemia and Thalassemia (Guest Editors: Elliott Vichinsky, Griffin P. Rodgers and Eliezer Rachmilewitz)] (2008) (0)
[Gene therapy]. (1982) (0)
Successful Induction of a Rapid Improvement of Both Clinical and Laboratory Parameters in a Patient with Advanced CLL by Combining Rituximab with Fresh Frozen Plasma as a Source for Complement. A Novel Therapeutic Approach (2005) (0)
Retrospective Analysis of Clinical Parameters and Survival Data in Patients with Chronic Lymphocytic Leukemia of Younger Versus Older Age Groups. (2005) (0)
Sickle cell disease inSicily (1980) (0)
Hydrolase Activities in Normoblasts of β - Thalassemic Patients (1979) (0)
Kinetic of Iron Absorption and Expression of Iron Related Genes in Beta-Thalassemia. (2005) (0)
The Red Blood Cell In Thalassemia * (2019) (0)
Subject Index, Vol. 70, 1983 (1983) (0)
Addition of Fresh Frozen Plasma to Rituximab Induces a Major Clinical and Laboratory Response in Patients with Refractory Advanced CLL. (2006) (0)
[Hemoglobin A1 c and evaluation of balance and complications of diabetes]. (1978) (0)
Index rerum ad Vol. 60 (1978) (0)
An EPR Study of the Precipitated Forms of Hemoglobin in Heinz Bodies from Patients with Alpha-Thalassemia1 (1971) (0)
Separation of RBC Age-related Subpopulations (2003) (0)
Iconography : Iron overload in hematological disorders (2017) (0)
Cardiac and pancreatic iron overload evaluation of sickle/β-Thalassemia patients utilizing T2* MRI (2009) (0)
[Desferrioxamine in thalassemia]. (1983) (0)
Coagulation Markers Levels Measured during Acute Infection May Predict the Development of Long Term Cardio- and Cerebro-Vascular Events in Elderly. (2007) (0)
in fl-Thalassemia Major (2017) (0)
Fludarabine in the treatment of refractory lymphocytic leukemia (CLL) and low grade lymphoma (LGL) (1993) (0)
[Editorial: New observations on thalassaemia]. (1974) (0)
Molecular analysis of beta-thalassemia in Israeli ethnic groups and its application to prenatal diagnosis (1992) (0)
[Improvement in the treatment of acute lymphoblastic leukemia in childhood]. (1987) (0)
Comparison of Overt and Cryptic Labile Plasma Iron In Thalassemia Patients In Israel and Gaza-Palestine (2010) (0)
erythropoiesis in Decreased differentiation of erythroid cells exacerbates ineffective (2008) (0)
[Blood transfusion in thalassemia--the Jerusalem experience]. (1985) (0)
In Vitro and In Vivo Antioxidant Effect of Fermented Papaya Preparation (FPP) on Blood Cells of Beta-Thalassaemia Patients. (2006) (0)
Subject Index, Vol. 62, 1979 (1979) (0)
Absence of functional beta-globin messenger RNA in Kurdish Jews with beta0-thalassemia. (1978) (0)
Acute promyelocytic leukemia in childhood. Report of a case with a review of the literature. (1979) (0)
Faculty Opinions recommendation of Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia. (2017) (0)
Index autorum ad Vol. 60 (1978) (0)
SP-003 IMPACT OF IRON OVERLOAD AND POTENTIAL BENEFIT FROM IRON CHELATION IN LOW-RISK MYELODYSPLASTIC SYNDROME AND BEFORE AND AFTER BMT (2014) (0)
[Premature partial fusion of epiphyses in thalassemia]. (1983) (0)
Faculty Opinions recommendation of Knockdown of transcription factor forkhead box O3 (FOXO3) suppresses erythroid differentiation in human cells and zebrafish. (2017) (0)
A beta°-Thalassemia intermedia. (1978) (0)
Contents, Vol. 60, 1978 (1978) (0)
Thalassemia Major and Intermedia in Older Patients – a Single Center Experience (2014) (0)
The Relevance of Mean Corpuscular Volume of Heterozygotes to Prenatal Diagnosis of β‐Thalassemia a (1990) (0)
erythroleukemic cells Iron storage in ferritin following intracellular hemoglobin denaturation in (2012) (0)
intermedia Calcium transport and ultrastructure of red cells in beta-thalassemia (2011) (0)
Faculty Opinions recommendation of Induction of fetal hemoglobin through enhanced translation efficiency of γ-globin mRNA. (2017) (0)
COMPLEMENT-MEDIATED HEMOLYSIS: THE INVOLVEMENT OF OXIDATIVE STRESS AND THE AMELIORATING EFFECT OF FERMENTED PAPAYA PREPARATION (2016) (0)
STUDIES ON HEMOGLOBIN. II. THE EFFECT OF ANTI-HEMOGLOBIN SERA ON THE RED BLOOD CELLS IN VITRO AND IN VIVO. (1963) (0)
A patient of German descent with (delta beta)0-thalassemia carrying the Sicilian type deletion of the delta and beta globin genes. (1988) (0)
of the JAK2 pathway Mechanisms of endothelial cell protection by blockade (2010) (0)
Faculty Opinions recommendation of miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction. (2017) (0)
58. The potential of human myeloid leukemic cells to undergo spontaneous differentiation in vitro and their response to differentiation-inducing-agents (1992) (0)
Potential Use of Jak2 Inhibitors to Limit Ineffective Erythropoiesis and Reverse Splenomegaly in β-Thalassemia. (2008) (0)
[Editorial: Sickle cell disease]. (1975) (0)
Sickle cell disease in Sicily phosphate (0)
Globin synthesis in bone marrow cells of patients with sickle cell anemia and beta O-thalassemia: contamination of the beta-chain with non-globin proteins. (1979) (0)
Faculty Opinions recommendation of Functional footprinting of regulatory DNA. (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Eliezer A. Rachmilewitz?

Eliezer A. Rachmilewitz is affiliated with the following schools:

Eliezer A. Rachmilewitz's Academic­Influence.com Rankings

Why Is Eliezer A. Rachmilewitz Influential?

Eliezer A. Rachmilewitz's Published Works

Published Works

What Schools Are Affiliated With Eliezer A. Rachmilewitz?

Eliezer A. Rachmilewitz's AcademicInfluence.com Rankings